CENTONZE, DIEGO
 Distribuzione geografica
Continente #
EU - Europa 390
AS - Asia 325
NA - Nord America 315
SA - Sud America 1
Totale 1.031
Nazione #
US - Stati Uniti d'America 297
DE - Germania 219
SG - Singapore 164
HK - Hong Kong 147
IT - Italia 102
EE - Estonia 18
CA - Canada 17
FI - Finlandia 12
GB - Regno Unito 11
BE - Belgio 8
PK - Pakistan 7
RU - Federazione Russa 7
LT - Lituania 6
NL - Olanda 6
BD - Bangladesh 4
IL - Israele 3
BR - Brasile 1
CH - Svizzera 1
MX - Messico 1
Totale 1.031
Città #
Hong Kong 147
Falkenstein 131
Frankfurt am Main 81
West Jordan 66
Rome 65
Chicago 64
Singapore 40
Boardman 39
Helsinki 12
Santa Clara 10
Toronto 10
Brussels 8
Buffalo 7
Moscow 7
Ottawa 7
Elk Grove Village 6
London 6
Naples 5
Ashburn 4
Bologna 4
Sant'Elpidio a Mare 4
Arosio 3
Charlotte 3
Ettlingen 3
Galbiate 3
Amsterdam 2
Zona Industriale 2
Council Bluffs 1
Grellingen 1
Kiryat Ono 1
Los Angeles 1
Mexico City 1
Milan 1
Raviscanina 1
São Paulo 1
Totale 747
Nome #
Dopaminergic dysfunction is associated with IL-1??-dependent mood alterations in experimental autoimmune encephalomyelitis 28
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients 27
Interaction between interleukin-1?? and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 27
Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity 25
Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis 25
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis 24
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis 24
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis 23
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis 23
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis 23
IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis 21
Interaction between miR-142-3p and BDNF Val/Met Polymorphism Regulates Multiple Sclerosis Severity. 21
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis. 21
Exploiting the multifaceted effects of cannabinoids on mood to boost their therapeutic use against anxiety and depression 21
Obesity worsens central inflammation and disability in multiple sclerosis 21
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 21
Case Report: Overlap Between Long COVID and Functional Neurological Disorders 21
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis 20
Osteopontin Is Associated with Multiple Sclerosis Relapses 20
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 20
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis 20
Inflammation and Corticospinal Functioning in Multiple Sclerosis: A TMS Perspective 20
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis 20
Interleukin-1β Alters Hebbian Synaptic Plasticity in Multiple Sclerosis 20
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis 19
Amyloid-β homeostasis bridges inflammation, synaptic plasticity deficits and cognitive dysfunction in multiple sclerosis 19
Transient receptor potential vanilloid 1 modulates central inflammation in multiple sclerosis 19
A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment 19
Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients 19
Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model 19
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 18
Synaptic plasticity shapes brain connectivity: Implications for network topology 18
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity 18
Practice-dependent motor cortex plasticity is reduced in non-disabled multiple sclerosis patients 16
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis 16
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 16
Preventive exercise and physical rehabilitation promote long-term potentiation-like plasticity expression in patients with multiple sclerosis 15
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 15
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 15
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 15
Remodeling functional connectivity in multiple sclerosis: A challenging therapeutic approach 15
Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum 15
Subclinical dysphagia in task-specific mouth tremor triggered by drinking 14
Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression 14
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis 14
A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum 14
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 14
Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons 14
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation. 14
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 14
Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis 14
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 14
miR-142-3p Is a Key Regulator of IL-1??-Dependent Synaptopathy in Neuroinflammation 13
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 13
Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake 13
Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions 12
Usability of an application device for nabiximols oromucosal spray in patients with upper limb impaired multiple sclerosis 12
Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation 12
'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting 12
Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis 12
Interleukin-1 Alters Glutamate Transmission at Purkinje Cell Synapses in a Mouse Model of Multiple Sclerosis 11
Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination 11
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis 10
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis 10
Totale 1.123
Categoria #
all - tutte 9.609
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.609


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024219 0 0 0 0 0 0 52 0 0 137 15 15
2024/2025904 40 49 7 69 105 76 232 231 67 28 0 0
Totale 1.123